Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00282776 · ClinicalTrials.gov registry record · Phase 3
Identification and Therapy of Postpartum Depression
A Phase 3 study of Depression, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 3
- Development phase
- 628
- Enrollment target
- 1
- Study location
NCT00282776 is a Phase 3 study of Depression that has completed, run by University of Pittsburgh. The registered enrollment target is 628 participants, below the 785-participant average among 679 other Depression trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00282776, a Phase 3 study of Depression, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 628 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effectiveness of a telephone-based depression screening and care management program in treating depression in postpartum women.
Conditions Studied
Interventions
- BEHAVIORAL TAU
- BEHAVIORAL Care Management for Postpartum Depression
Study Locations (1)
Pennsylvania
- Women's Behavioral HealthCARE Program, Suite 410, 3501 Forbes Ave - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 628 participants |
| Start Date | 2006-08 |
| Est. Completion | 2012-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00282776
The ClinicalTrials.gov registry entry for NCT00282776 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 628 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 785-participant average among 679 other Depression trials with a reported enrollment target (20% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which TAU is the first listed.
NCT00282776 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00282776 about?
NCT00282776 is a clinical study titled "Identification and Therapy of Postpartum Depression". This study will evaluate the effectiveness of a telephone-based depression screening and care management program in treating depression in postpartum women.
What is the current status of trial NCT00282776?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 628 participants. The study started on 2006-08. Estimated completion is 2012-03.
What conditions does trial NCT00282776 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT00282776?
The interventions under investigation include: TAU (BEHAVIORAL), Care Management for Postpartum Depression (BEHAVIORAL).
Who is sponsoring clinical trial NCT00282776?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00282776 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care
RECRUITING · Phase 3
-
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RECRUITING · Phase 3
-
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
RECRUITING · Phase 3
-
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
RECRUITING · Phase 3
-
Creatine for Depressed Male and Female Methamphetamine Users
RECRUITING · Phase 3
-
E-Mindfulness Approaches for Living After Breast Cancer
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.